A new paradigm in therapeutic development is emerging as Remepy, a pioneering startup, successfully completed a Phase IIa clinical trial…
Read More
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Researchers at King’s College London have identified a promising new therapeutic strategy for Alzheimer’s disease by targeting several of the…
Read More
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
The global plastic crisis has reached a critical juncture, with production levels exceeding 400 million tonnes annually and a significant…
Read More
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Sanofi has announced a significant strategic decision to halt the development and forgo filing for approval of its immunology therapy,…
Read More
5 Key Concepts Behind Agentic AI Every Engineer Must Understand
The landscape of artificial intelligence is rapidly evolving beyond mere information retrieval to proactive task execution, marking a profound shift…
Read More
The Hidden Cellular Motor: New Research Uncovers a Pulling Force Driving Human Hair Growth
For decades, the established understanding of human hair growth, as presented in biology textbooks worldwide, centered on a seemingly straightforward…
Read More
TWiV 1287: Ancient Herpesviruses and Modern Dementia
In a recent episode of the esteemed podcast "This Week in Virology" (TWiV), hosts Vincent Racaniello, Alan Dove, Rich Condit,…
Read More
Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921
Science News, a venerable institution in the realm of science journalism, has been dedicated to delivering accurate and accessible information…
Read More
As cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
The biopharmaceutical industry is grappling with a profound challenge: the silent erosion of critical process knowledge, particularly "tacit knowledge," during…
Read More
Buck Institute Study Reveals How APOE2 Gene Protects Against Alzheimer’s and Promotes Longevity through DNA Repair and Senescence Resistance
For decades, the genetic landscape of Alzheimer’s disease has been dominated by the study of the apolipoprotein E (APOE) gene.…
Read MoreYOU MAY HAVE MISSED
